Novavax (NVAX) Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. AAPL
6. RTB
7. ONON
8. AZN
9. SPCX
10. TRMD

Go back to Novavax (NVAX) Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.11 +0.11 (1.10%)
Previous Close $10.00    52 Week High $9.23 
Open $9.89    52 Week Low $1.16 
Day High $10.15    P/E N/A 
Day Low $9.76    EPS $-0.30 
Volume 11,145,262